| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5921123 | Cardiovascular Revascularization Medicine | 2015 | 5 Pages |
Abstract
Among Hispanic patients with stable CAD, ticagrelor achieves a faster onset and greater magnitude of platelet inhibition compared with clopidogrel, irrespective of diabetic status.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Leonardo C. Clavijo, Juan Maya, Glenn Carlson, Dominick J. Angiolillo, Renli Teng, Richard Caplan, Matthew J. Price,